ClinicalTrials.Veeva

Menu

Non-hypovascular Solid Pancreatic Lesions: Role of EUS (LE-VASC)

I

Integrated University Hospital Trust of Verona

Status

Completed

Conditions

Solid Pancreatic Neoplasms
Endoscopic Ultrasound

Treatments

Diagnostic Test: Endoscopic ultrasound-fine needle biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT03738280
1296CESC

Details and patient eligibility

About

Vascular pattern of solid pancreatic lesions (SPLs) has been investigated by different abdominal imaging modalities and by contrast-enhanced endoscopic ultrasonography (CE-EUS). Compared with surrounding pancreatic parenchyma three different patterns have been described: hypo-, iso-, and hypervascular. The majority of SPLs are hypovascular, and the diagnostic relevance of hypoenhanced pattern to predict pancreatic adenocarcinoma (PDAC) is well established. Differently, iso- and hypervascular pattern is not specific and can be expressed by several SPLs, with different clinical behavior and management. To date, poor is know about the role of EUS in differential diagnosis of non-hypovascular SPLs and features associated with malignancy.

Enrollment

154 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Presence of one or more solid pancreatic lesions preliminary evaluated by contrast-enhanced computed tomography (CE-CT) and/or contrast enhanced magnetic resonance imaging (CE-MRI) reporting a non-hypovascular contrast pattern (e.g., iso- or hypervascular).

Exclusion criteria

  • Patients with associated chronic pancreatitis features (e.g., pancreatic calcifications)
  • Lesion with hypovascular pattern at CE-EUS.
  • Lesion not found or non pancreatic at EUS.
  • Patients refusing to be included in the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems